基因组风险预测在大型欧洲裔老年人前瞻性研究中对抑郁的预测
本研究在12,029名≥70岁欧洲裔老年人中探讨多基因评分(PGS)与抑郁结局的关联,随访中位4.7年。PGS与基线抑郁、新发抑郁、抗抑郁药使用及抑郁轨迹严重程度均显著相关,提示PGS可能有助于晚发抑郁的风险分层。
要点
- PGS每增加1个标准差,基线抑郁OR=1.23,新发抑郁HR=1.18,抗抑郁药使用OR=1.39。
- PGS与抑郁轨迹严重程度相关:亚阈值OR=1.15,新发上升OR=1.22,持续抑郁OR=1.40。
- 在≥70岁欧洲裔老年人中,PGS可能用于晚发抑郁的风险分层。
核心结论
- PGS与晚发抑郁的基线患病、新发抑郁、抗抑郁药使用及抑郁轨迹严重程度均显著相关,可能对风险分层有重要作用。
研究设计与样本
- 前瞻性纵向队列研究,纳入12,029名≥70岁欧洲裔老年人,基线无心血管疾病事件、痴呆或永久性躯体残疾史,随访中位4.7年。
- PGS基于最新精神疾病基因组学联盟重性抑郁数据构建,采用多变量模型校正协变量后分析PGS(每标准差)与抑郁结局的关联。
主要发现
- 基线平均年龄75.1岁,女性占54.9%,9.1%存在抑郁(CES-D-10≥8)。
- PGS与基线抑郁(OR=1.23 [1.15-1.31])、新发抑郁(HR=1.18 [1.14-1.23])及抗抑郁药使用(OR=1.39 [1.31-1.47])显著相关。
- 相较于非抑郁者,PGS与抑郁轨迹类别严重程度增加相关:亚阈值抑郁OR=1.15 [1.11-1.20],新发抑郁OR=1.22 [1.13-1.31],持续抑郁OR=1.40 [1.31-1.49]。
关键数值与推荐
- 抑郁主要结局定义为CES-D-10评分≥8,次要结局为≥10和≥12,同时使用抗抑郁药及四种纵向抑郁轨迹(低/非抑郁、中等/亚阈值、高/持续、初始低但上升/新发)。
临床怎么用
- 在≥70岁欧洲裔老年人中,可考虑将PGS作为晚发抑郁风险分层的辅助工具,结合临床评估识别高风险个体。
局限性
- 研究仅纳入欧洲裔老年人,结果外推至其他种族或年龄人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The extent to which genetic predisposition contributes to late-life depression risk, particularly after age 70, remains unclear, despite the high prevalence of depression in this age group and the variability in risk factors by age. This study investigated the association between a polygenic score (PGS) and depression outcomes, including severity, trajectories of depression, and antidepressant medication use, in a longitudinal cohort of 12,029 genotyped older adults of European descent aged ≥70 years, with no history of diagnosed cardiovascular disease events, dementia, or permanent physical disability at baseline. Participants were followed for a median of 4.7 years. The PGS was derived using the latest Psychiatric Genomics Consortium data for major depression. Depression was defined by the CES-D-10 score thresholds of ≥8 (primary outcome), ≥10, and ≥12 (secondary outcomes), alongside antidepressant medication use and four previously established longitudinal trajectories of depressive symptoms: low (non-depressed), moderate (subthreshold), high (persistent), and initially low but increasing (emerging). Multivariable models were used to examine associations between the PGS (per standard deviation, SD) and outcomes, adjusting for covariates. At baseline, mean participant age was 75.1 years, 54.9% were female, and 9.1% had depression (CES-D-10 ≥ 8). The PGS was significantly associated with baseline depression (OR = 1.23 [1.15-1.31]), incident depression (HR = 1.18 [1.14-1.23]) and antidepressant medication use (OR = 1.39 [1.31-1.47]). Compared with non-depressed participants, the PGS was associated with increasing severity of depression trajectory classes (subthreshold depression OR = 1.15 [1.11-1.20], emerging depression OR = 1.22 [1.13-1.31], persistent depression OR = 1.40 [1.31-1.49]). These findings suggest that the PGS may play an important role in risk stratification for late-life depression.
引用
- Yu C, Bakshi A, Agustini B, et al. Genomic risk prediction for depression in a large prospective study of older adults of European descent. Mol Psychiatry. 2025. PMID: 40770434. doi:10.1038/s41380-025-03145-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。